KRX/249420 (KRX/249420)

Korea Stock Exchange: KRX/249420 · KRW

₩12,790

+140.41 (+1.1%)· Recorded snapshot

Market cap	403B
Revenue (ttm)	582.3B
Net income (ttm)	43.6B
EPS (ttm)	₩1,375
Shares out	31.5M
P/E (trailing)	9.3x
Dividend	₩200 (1.56%)
Volume	84,269
Beta	0.89

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 582.3B
Net income (ttm): 43.6B
EPS (ttm): ₩1,375
P/E (trailing): 9.3x
Market cap: 403B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 7P50 11.1P75 20.3

Trailing P/E9.3

P25 7.2P50 12.6P75 23.6

ROE18.5

P25 -16.3P50 0.9P75 9.4

ROIC6.5

P25 -9.5P50 1.6P75 7.2

Benchmarks · 1M

All KRX/249420 indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

KRW

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Earnings date	2026-11-13
Employees	1,050
Enterprise value	KRW 476.3B
Exchange	Korea Stock Exchange
Financial currency	KRW
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1941
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	KR7249420001
Last earnings date	2026-05-13
Last refreshed	2026-10-28
Last stock split date	2020-03-05
Last stock split type	Forward
Market cap	KRW 403B
Next earnings date	2026-11-13
Price	KRW 12,790.00
Price currency	KRW
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	krx/249420
Website	https://www.ildong.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	10.75%
EV/Earnings	10.92x
EV/EBIT	18.11x
EV/EBITDA	9.85x
EV/FCF	21.23x
EV/Sales	0.82x
FCF / EV yield	4.71%
FCF yield	5.57%
Graham number	15917.22535
Graham upside	24.45%
Industry forward P/E	13.86x
Industry P/E	18.58x
P/(FCF - SBC) ratio	17.99x
P/(OCF - SBC) ratio	11.38x
P/B ratio	1.55x
P/E ratio	9.3x
P/FCF ratio	17.97x
P/OCF ratio	11.37x
P/S ratio	0.69x
Price / tangible book value	1.7x
Price/EBITDA ratio	8.46x
Sector forward P/E	24.95x
Sector P/E	49.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.39%
EBITDA margin	8.18%
Effective tax rate	15.9%
FCF margin	3.85%
Gross margin	39.59%
Operating margin	4.39%
Pretax margin	8.08%
Profit margin	7.49%
Profit per employee	KRW 41.5M
Profitable quarters	4
Profitable years	1
Revenue per employee	KRW 554.6M
ROA	2.79%
ROA (5Y)	-2.83%
ROCE	7.23%
ROE	18.5%
ROE (5Y)	-32.5%
ROIC	6.54%
ROIC (5Y)	-10.66%
SBC / revenue	0.01%
Tax / revenue	1.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-30.97%
EPS growth quarters	2
EPS growth years	3
FCF growth	238.47%
Gross profit growth	4.14%
Gross profit growth (Q)	5.37%
Gross profit growth 3Y	0.75%
Gross profit growth 5Y	0.2%
Net income growth (QoQ)	-31.08%
Net income growth quarters	2
Net income growth years	3
OCF growth	118.34%
OCF growth 5Y	37.8%
Operating income growth	63.82%
Operating income growth (Q)	455.73%
Revenue growth	-0.65%
Revenue growth (Q)	6.77%
Revenue growth (QoQ)	4.13%
Revenue growth 3Y	-1.84%
Revenue growth 5Y	0.77%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -13B
Depreciation and amortization	KRW 22.1B
EBIT	KRW 25.5B
EBITDA	KRW 47.6B
EPS	KRW 1,375.44
FCF per share	KRW 711.89
Financing cash flow	KRW -36.4B
Free cash flow	KRW 22.4B
Free cash flow minus SBC	KRW 22.4B
Gross profit	KRW 230.5B
Income taxes	KRW 7.5B
Investing cash flow	KRW -4.2B
Net borrowing	KRW -44.7B
Net cash flow	KRW -5.1B
Net income	KRW 43.6B
Operating cash flow minus SBC	KRW 35.4B
Operating income	KRW 25.5B
Revenue	KRW 582.3B
Stock-based compensation	KRW 33.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.23
Book value per share	KRW 8,186.74
Debt / EBITDA	2.75
Debt / equity	0.5
Debt / FCF	5.85
Goodwill	KRW 5.5B
Interest coverage	3.07
Long-term assets	KRW 341.9B
Long-term liabilities	KRW 93B
Net cash (debt)	KRW -70.8B
Net cash / market cap	-17.57%
Net debt / EBITDA	1.49
Net debt / equity	0.27
Net debt / FCF	3.16
Piotroski F-Score	6
Property, plant and equipment	KRW 215.5B
Shareholders' equity	KRW 260.5B
Tangible book value	KRW 236.8B
Tangible book value per share	KRW 7,516.03
Total assets	KRW 560.5B
Total cash	KRW 60.4B
Total debt	KRW 131.2B
Total liabilities	KRW 300B
WACC	8.22%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.02
Current assets	KRW 218.6B
Current liabilities	KRW 207.1B
Current ratio	1.06
Inventory turnover	3.62
Net working capital	KRW 61.2B
Quick ratio	0.56
Working capital	KRW 11.5B
Working capital turnover	-21.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-16.43%
Dividend growth	0%
Dividend growth (3Y)	-19.33%
Dividend growth (5Y)	-12.09%
Dividend growth years	2
Dividend payment date	2026-04-24
Dividend payment years	1
Dividend per share	KRW 200.00
Dividend yield	1.56%
Ex-dividend date	2026-03-30
FCF payout ratio	28.09%
Last dividend	KRW 200.00
Payout ratio	14.45%
Shareholder yield	-14.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-13.39%
10Y return CAGR	-0.87%
10Y total return	-8.38%
150-day SMA	KRW 18,867.47
1D price change	1.11%
1M price change	-7.59%
1M total return	-7.59%
1W price change	-4.84%
1W total return	-4.84%
1Y price change	-48.32%
1Y return CAGR	-48%
1Y total return	-47.98%
20-day SMA	KRW 13,559.00
200-day SMA	KRW 23,354.60
3M price change	-9.03%
3M total return	-9.03%
3Y price change	-21.29%
3Y return CAGR	-7.46%
3Y total return	-20.77%
50-day SMA	KRW 14,280.40
50-day SMA vs 200-day SMA	50under200
52-week high	KRW 45,050.00
52-week high date	2025-12-12
52-week low	KRW 11,250.00
52-week low date	2026-07-30
5Y price change	-11.79%
5Y return CAGR	-2.35%
5Y total return	-11.21%
6M price change	-54.48%
6M total return	-54.48%
All-time high	KRW 79,500.00
All-time high date	2022-04-06
All-time low	KRW 9,280.00
All-time low date	2020-03-19
Average true range (ATR)	KRW 564.31
Average volume	122.1K
Beta (1Y)	0.42
Beta (2Y)	0.5
Beta (5Y)	0.89
Change from 52-week high	-71.61%
Change from 52-week low	13.69%
Change from all-time high	-83.91%
Change from all-time low	37.82%
Change from open	0.16%
Day's gap	0.95%
Dollar volume	KRW 1.1B
High price	KRW 13,040.00
Low price	KRW 12,640.00
Monthly RSI	40.29
Open price	KRW 12,770.00
Position in 52-week range	37.5%
Previous close	KRW 12,650.00
Price vs 150-day SMA	-32.21%
Price vs 20-day SMA	-5.67%
Price vs 200-day SMA	-45.24%
Price vs 50-day SMA	-10.44%
Relative volume	0.69
RSI	39.6
Sharpe ratio	-0.46
Sharpe ratio (3Y)	-0
Sharpe ratio (5Y)	0.31
Sortino ratio	-0.63
Sortino ratio (3Y)	0.1
Sortino ratio (5Y)	0.62
Volume	84.3K
Weekly RSI	31.29
YTD price change	-66.78%
YTD total return	-66.56%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20.6M
Shares change (QoQ)	-0.05%
Shares change (YoY)	16.43%
Shares held by insiders	2.11%
Shares held by institutions	3.79%
Shares outstanding	31.5M

Deeper analysis on KRX/249420

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this KRX/249420 report

Is a complete KRX/249420 research report available?

No complete published report is available for krx/249420 (KRX/249420) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

KRX/249420 (KRX/249420)

Price

Financial snapshot

Fair-value bridge

Latest news · KRX/249420

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KRX/249420 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KRX/249420

Frequently asked questions